Search

Your search keyword '"Brassard, Nathalie"' showing total 165 results

Search Constraints

Start Over You searched for: Author "Brassard, Nathalie" Remove constraint Author: "Brassard, Nathalie"
165 results on '"Brassard, Nathalie"'

Search Results

1. Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity

2. Circulating proteins to predict COVID-19 severity

5. Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120

6. A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile

7. An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells

8. Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

9. The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

11. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

12. HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes.

13. Excess BAFF May Impact HIV-1-Specific Antibodies and May Promote Polyclonal Responses Including Those from First-Line Marginal Zone B-Cell Populations

14. 178 Tumor neoantigen prioritization from liquid biopsy whole exome sequencing for selected tumor-infiltrating lymphocyte therapy

15. Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease

16. Abstract 4052: Direct selection of PD1+ CD39+ tumor infiltrating lymphocytes (TIL) from tumor dissociates enrich for functional tumor-reactive cells

17. Abstract 4049: TIDAL-01: A selected TIL process that enriches for neoantigen reactive TIL in solid tumors

18. Excess BAFF Alters NR4As Expression Levels and Breg Function of Human Precursor-like Marginal Zone B-Cells in the Context of HIV-1 Infection

20. CD4 mimetics sensitize HIV-1-infected cells to ADCC

21. Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function

22. A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile

23. A long interval between priming and boosting SARS-CoV-2 mRNA vaccine doses enhances B cell responses with limited impact on T cell immunity

24. Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen

25. Additional file 6 of The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

26. Additional file 1 of The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

27. Additional file 2 of The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

28. Additional file 3 of The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

29. Additional file 5 of The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

30. Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen

31. The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals

32. Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality

33. Immune checkpoint expression on HIV-specific CD4+ T cells and response to their blockade are dependent on lineage and function

34. A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses

35. Mapping the human genetic architecture of COVID-19

36. Identification of SARS-CoV-2–specific immune alterations in acutely ill patients

37. A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses

38. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset

39. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients

40. Persistent expansion and Th1-like skewing of HIV-specific circulating T follicular helper cells during antiretroviral therapy

43. Immune Checkpoint Blockade Restores HIV-Specific CD4 T Cell Help for NK Cells

44. Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses

45. Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells

47. BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity

48. Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses

50. Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins

Catalog

Books, media, physical & digital resources